BTK and Muckle-Wells syndrome: BTK is associated with NLRP3 and ASC and promotes ASC speck formation and caspase-1 cleavage (83), with the BTK inhibitor ibrutinib shown to be effective in blocking IL-1β secretion in immune cells derived from Muckle-Wells syndrome patients (83).